Delivery Order SPE2DR25D3015-SPE2DR26F4GS2
Award Date 1/27/26
Potential Completion Date 2/18/26
Potential Value $7.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 11, 2026, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $7,748.39 for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 9, 2025. The order will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a leading pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $7,748.39 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitive award, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $7,352.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a completion deadline of November 19, 2025. This non-set-aside competitive award reflects the company's established capability to meet federal pharmaceutical procurement requirements. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,748.39 to Amerisourcebergen Drug Corp for the supply of Erleada 240 mg tablets (30-count unit dose packaging) with a completion date of February 19, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is being performed at the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Erleada 60 mg tablets (120-count units) valued at $7,965.80, with completion scheduled for February 5, 2026. This firm fixed-price contract award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to Amerisourcebergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with a completion date of February 9, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Erleada 240 mg tablets in quantities of 30 units. This $7,748.39 firm fixed-price delivery order, with completion scheduled for February 18, 2026, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where...